Wellgistics Health and DataVault AI signed a non-binding letter of intent to develop a blockchain-enabled solution for prescription drug tracking and fulfillment.
UniFirst reported increased full-year net income and EPS for fiscal 2025, despite a Q4 decline, and provided its fiscal 2026 outlook.
HomeTrust Bancshares declared an increased quarterly dividend to $0.13 per share and reported nine-month net income of $48.2 million, up 18.8% year-over-year.
Summit Therapeutics secured $500 million in gross proceeds from a private placement of common stock to advance ivonescimab development and for general corporate purposes.
Taylor Morrison Home reported Q3 net income of $201 million, or $2.01 diluted EPS, and raised full-year guidance for home closings and gross margin.
Oncotelic CEO Dr. Vuong Trieu presented an investor corporate presentation at LD Micro, outlining future strategy and product development.